Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Cell Stem Cell|January 7, 2017
Seq-ing Markers of Midbrain Dopamine NeuronsTeresia Osborn, Penelope J Hallett
Movement Disorders : Official Journal of the Movement Disorder Society|November 8, 2006
Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesiaPenelope J Hallett, J M Brotchie
Pharmacology & Therapeutics|May 28, 2004
Rationale for and use of NMDA receptor antagonists in Parkinson's diseasePenelope J Hallett, David G Standaert
International Review of Neurobiology|August 3, 2020
Experimental studies of mitochondrial and lysosomal function in in vitro and in vivo models relevant to Parkinson's disease genetic riskRia Thomas, Penelope J Hallett, Ole Isacson
Journal of Neuroinflammation|July 24, 2019
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson's diseasePenelope J Hallett, Simone Engelender, Ole Isacson
Frontiers in Neurology|October 26, 2019
Novel Results and Concepts Emerging From Lipid Cell Biology Relevant to Degenerative Brain Aging and DiseaseOle Isacson, Oeystein R Brekk, Penelope J Hallett
Scientific Reports|October 14, 2018
Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with ageOeystein R Brekk, Alyssa Moskites, Ole Isacson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2009
Functional enhancement and protection of dopaminergic terminals by RAB3B overexpressionChee Yeun Chung, James B Koprich, Penelope J Hallett, et al.
Frontiers in Cellular Neuroscience|April 23, 2020
Advantages and Recent Developments of Autologous Cell Therapy for Parkinson's Disease PatientsTeresia M Osborn, Penelope J Hallett, James M Schumacher, et al.
Molecular and Cellular Neurosciences|December 14, 2011
Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpressionJesse R McLean, Penelope J Hallett, Oliver Cooper, et al.
Pageof 5